# China NMPA Product Recall - Morphine/Methamphetamine Combination Test Kit (Colloidal Gold Method)

Source: https://www.globalkeysolutions.net/records/china_product_recall/shanghai-hu-an-biotechnology-co-ltd/995840bf-3f7c-4bfd-bf9f-a946f086b496/
Source feed: China

> China NMPA product recall for Morphine/Methamphetamine Combination Test Kit (Colloidal Gold Method) by Shanghai Hu An Biotechnology Co., Ltd. published November 13, 2017. Recall level: Level 3 Recall. Shanghai Batong Biotechnology Co., Ltd. has initiated a voluntary Class III recall of its Morphine/M

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Shanghai Batong Biotechnology Co., Ltd. is voluntarily recalling its morphine/methamphetamine dual-use test kit (colloidal gold method).
- Company Name: Shanghai Hu An Biotechnology Co., Ltd.
- Publication Date: 2017-11-13
- Product Name: Morphine/Methamphetamine Combination Test Kit (Colloidal Gold Method)
- Recall Level: Level 3 Recall
- Recall Reason: The aluminum foil bag did not include information such as the registration certificate.
- Discovering Company: Shanghai Batong Biotechnology Co., Ltd.
- Manufacturing Company: Shanghai Hu An Biotechnology Co., Ltd.
- Summary: Shanghai Batong Biotechnology Co., Ltd. has initiated a voluntary Class III recall of its Morphine/Methamphetamine Combination Test Kit (Colloidal Gold Method), registered under NMPA No. 20173401204. The National Medical Products Administration (NMPA) document, published on November 13, 2017, outlines the reason for this action. The primary violation identified was that the aluminum foil packaging for the affected product batches failed to include the necessary registration certificate information. This omission represents a non-compliance with regulatory requirements concerning product labeling and traceability. The recall ensures that products not adhering to these critical labeling standards are removed from circulation. A Class III recall typically indicates a situation where the use of, or exposure to, a violative product is not likely to cause adverse health consequences. While specific inspection dates are not detailed in the provided document, the NMPA oversees this regulatory action. The company is required to provide comprehensive details regarding the affected models, specifications, and batch numbers through a "Medical Device Recall Event Report Form" to the NMPA, ensuring proper management of the recall process. This action underscores the importance of strict adherence to labeling regulations for medical devices.

Company: https://www.globalkeysolutions.net/companies/shanghai-hu-an-biotechnology-co-ltd/bbe90b5e-84e0-4b77-bdb8-6de9c4e52126/